Disposition of 700761 shares by Graham G. Walmsley of Olema Pharmaceuticals at 6.75 subject to Rule 16b-3

OLMA Stock  USD 6.12  0.00  0.00%   
About 67% of Olema Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Olema Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Olema Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Olema Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Olema Pharmaceuticals Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 700761 common stock at 6.75 of Olema Pharmaceuticals by Graham G. Walmsley on 13th of December 2024. This event was filed by Olema Pharmaceuticals with SEC on 2024-12-13. SEC Form: Changes in beneficial ownership

Cash Flow Correlation

Olema Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Olema Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Olema Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Olema Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Olema Pharmaceuticals Fundamental Analysis

We analyze Olema Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Olema Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Olema Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Olema Pharmaceuticals is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Olema Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Olema Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Olema Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Olema Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Olema Pharmaceuticals Related Equities

CNTACentessa Pharmaceuticals   6.97   
0%
94.0%
ERASErasca   4.08   
0%
55.0%
LRMRLarimar Therapeutics   3.02   
0%
40.0%
PHVSPharvaris   2.76   
0%
37.0%
MLYSMineralys Therapeutics,   1.63   
0%
22.0%
OBIOOrchestra BioMed   0.84   
0%
11.0%
FENCFennec Pharmaceuticals   0.68   
0%
9.0%
DSGNDesign Therapeutics   0.67   
0%
9.0%
NVCTNuvectis Pharma   0.21   
0%
2.0%
CGEMCullinan Oncology   0.00   
0%
0%
ZNTLZentalis Pharmaceuticals   0.00   
0%
0%
SANASana Biotechnology   1.18   
15.0%
0%
MOLNMolecular Partners   1.51   
20.0%
0%
IRONDisc Medicine   2.31   
31.0%
0%
ANTXAN2 Therapeutics   3.05   
41.0%
0%
PEPGPepGen   5.58   
75.0%
0%
GLUEMonte Rosa   7.40   
100.0%
0%

Complementary Tools for Olema Stock analysis

When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets